SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Ribas, Antoni, Medina, Theresa, Kummar, Shivaani, Amin, Asim, Kalbasi, Anusha, Drabick, Joseph J, Barve, Minal, Daniels, Gregory A, Wong, Deborah J, Schmidt, Emmett V, Candia, Albert F, Coffman, Robert L, Leung, Abraham C F, Janssen, Robert S
Published in Cancer discovery (01.10.2018)
Published in Cancer discovery (01.10.2018)
Get full text
Journal Article
Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
Jackson, Sam, Lentino, Joseph, Kopp, James, Murray, Linda, Ellison, William, Rhee, Margaret, Shockey, Gerald, Akella, Lalith, Erby, Kimberly, Heyward, William L., Janssen, Robert S., Adams, Michael, Bolshoun, David, Bruce, Tami, Chuang, Rita, DeSantis, Donna, Fiel, Thomas, Fitzgibbons, William, Francyk, David, Geisberg, Harry, Giep, Son, Godbole, Narendra, Haas, Terry, Halpern, Stephen, Inzerello, Anthony, Jennings, William, Kaiser, Scott, Kay, Jennifer, Kirby, William, Lending, Robert, Levins, Peter, Molin, Clifford, Noss, Michael, Kotek, Larry, Reynolds, Michele, Riffer, Ernie, Schumacher, Douglas, Severance, Randall, Solano, Royce, Tejada, Albert, Tharenos, Leslie, Throne, Martin, Turner, Merle, Wolf, Thomas, Woodruff, Mark
Published in Vaccine (29.01.2018)
Published in Vaccine (29.01.2018)
Get full text
Journal Article
Estimation of HIV Incidence in the United States
Hall, H. Irene, Song, Ruiguang, Rhodes, Philip, Prejean, Joseph, An, Qian, Lee, Lisa M, Karon, John, Brookmeyer, Ron, Kaplan, Edward H, McKenna, Matthew T, Janssen, Robert S, HIV Incidence Surveillance Group, for the
Published in JAMA : the journal of the American Medical Association (06.08.2008)
Published in JAMA : the journal of the American Medical Association (06.08.2008)
Get full text
Journal Article
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age
Heyward, William L, Kyle, Michael, Blumenau, Joseph, Davis, Matthew, Reisinger, Keith, Kabongo, Martin L, Bennett, Sean, Janssen, Robert S, Namini, Hamid, Martin, J. Tyler
Published in Vaccine (04.11.2013)
Published in Vaccine (04.11.2013)
Get full text
Journal Article
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
Richmond, Peter, Nolan, Terry, McGirr, Anthony, Napier-Flood, Fiona, Kim, Joshua, Leah, Amber, Xie, Fang, Campbell, John D., Godeaux, Olivier, Henry, Ouzama, Wood, Nicholas, Janssen, Robert S.
Published in Vaccine (24.10.2024)
Published in Vaccine (24.10.2024)
Get full text
Journal Article
Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease
Girndt, Matthias, Houser, Patricia, Manllo-Karim, Roberto, Ervin, John E., Charytan, Chaim, Chow, Stephen, Symonian-Silver, Margarita, Lehrner, Lawrence, Linfert, Douglas, Shemin, Douglas, Michelsen, Ann, Xie, Fang, Janssen, Robert S.
Published in Vaccine (11.05.2023)
Published in Vaccine (11.05.2023)
Get full text
Journal Article
Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination
Janssen, Robert S., Bruxvoort, Katia, Jacobsen, Steven J., Slezak, Jeff, David, Coline, Hyer, Randall, Poland, Gregory A.
Published in Vaccine (15.09.2021)
Published in Vaccine (15.09.2021)
Get full text
Journal Article
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs
Marks, Gary, Crepaz, Nicole, Senterfitt, J Walton, Janssen, Robert S
Published in Journal of acquired immune deficiency syndromes (1999) (01.08.2005)
Published in Journal of acquired immune deficiency syndromes (1999) (01.08.2005)
Get more information
Journal Article
Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age
Janssen, Julia M, Jackson, Sam, Heyward, William L, Janssen, Robert S
Published in Vaccine (17.07.2015)
Published in Vaccine (17.07.2015)
Get full text
Journal Article
Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease
Janssen, Robert S, Mangoo-Karim, Roberto, Pergola, Pablo E, Girndt, Matthias, Namini, Hamid, Rahman, Sophia, Bennett, Sean R, Heyward, William L, Martin, J. Tyler
Published in Vaccine (04.11.2013)
Published in Vaccine (04.11.2013)
Get full text
Journal Article
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
Girndt, Matthias, Plüer, Manfred, Dellanna, Frank, Michelsen, Ann K., Beige, Joachim, Toussaint, Kai, Wehweck, Hubert J., Koch, Michael, Hafezi Rachti, Syrus, Faust, Justus, Bosselmann, Hans-Peter, Witzke, Oliver, Janssen, Robert S.
Published in Human vaccines & immunotherapeutics (30.11.2022)
Published in Human vaccines & immunotherapeutics (30.11.2022)
Get full text
Journal Article
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis
Awad, Ahmed M., Ntoso, Adu, Connaire, Jeffrey J., Hernandez, German T., Dhillon, Kiranjit, Rich, Lisa, Henderson, Heather, Lynn, Robert, Hyer, Randall N., Xie, Fang, Erby, Kimberly, Janssen, Robert S.
Published in Vaccine (08.06.2021)
Published in Vaccine (08.06.2021)
Get full text
Journal Article
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus
Janssen, Julia M, Heyward, William L, Martin, J. Tyler, Janssen, Robert S
Published in Vaccine (11.02.2015)
Published in Vaccine (11.02.2015)
Get full text
Journal Article
Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trial
Waits, Alexander, Chen, Jau-Yuan, Cheng, Wei-Hong, Yeh, Jih-I, Hsieh, Szu-Min, Chen, Charles, Janssen, Robert, Lien, Chia En, Lin, Tzou-Yien
Published in International journal of infectious diseases (01.11.2022)
Published in International journal of infectious diseases (01.11.2022)
Get full text
Journal Article
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVCCOV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
Hsieh, Szu-Min, Liu, Wang-Da, Huang, Yu-Shan, Lin, Yi-Jiun, Hsieh, Erh-Fang, Lian, Wei-Cheng, Chen, Charles, Janssen, Robert, Shih, Shin-Ru, Huang, Chung-Guei, Tai, I-Chen, Chang, Shan-Chwen
Published in EClinicalMedicine (01.08.2021)
Published in EClinicalMedicine (01.08.2021)
Get full text
Journal Article
New developments in accelerated weathering tests for Back-contact modules
Meijers, Guido J.W., Janssen, Robert H. C, Pastukhov, Leonid, Duijnhoven, Frank van
Published in 2021 IEEE 48th Photovoltaic Specialists Conference (PVSC) (20.06.2021)
Published in 2021 IEEE 48th Photovoltaic Specialists Conference (PVSC) (20.06.2021)
Get full text
Conference Proceeding